PT77532B - Alkanolaminoxy derivatives of 3,3-dihydro-2h-1,4-benzothiazin-3-one their production process and their pharmaceutical use - Google Patents

Alkanolaminoxy derivatives of 3,3-dihydro-2h-1,4-benzothiazin-3-one their production process and their pharmaceutical use

Info

Publication number
PT77532B
PT77532B PT77532A PT7753283A PT77532B PT 77532 B PT77532 B PT 77532B PT 77532 A PT77532 A PT 77532A PT 7753283 A PT7753283 A PT 7753283A PT 77532 B PT77532 B PT 77532B
Authority
PT
Portugal
Prior art keywords
alkanolaminoxy
benzothiazin
dihydro
derivatives
production process
Prior art date
Application number
PT77532A
Other languages
English (en)
Other versions
PT77532A (en
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of PT77532A publication Critical patent/PT77532A/pt
Publication of PT77532B publication Critical patent/PT77532B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT77532A 1982-10-20 1983-10-19 Alkanolaminoxy derivatives of 3,3-dihydro-2h-1,4-benzothiazin-3-one their production process and their pharmaceutical use PT77532B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8249313A IT1212552B (it) 1982-10-20 1982-10-20 Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica

Publications (2)

Publication Number Publication Date
PT77532A PT77532A (en) 1983-11-01
PT77532B true PT77532B (en) 1986-02-12

Family

ID=11270308

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77532A PT77532B (en) 1982-10-20 1983-10-19 Alkanolaminoxy derivatives of 3,3-dihydro-2h-1,4-benzothiazin-3-one their production process and their pharmaceutical use

Country Status (8)

Country Link
US (1) US4535079A (pt)
EP (1) EP0106816A3 (pt)
JP (1) JPS59108773A (pt)
AU (1) AU2028283A (pt)
CA (1) CA1215366A (pt)
ES (1) ES526569A0 (pt)
IT (1) IT1212552B (pt)
PT (1) PT77532B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2996475B2 (ja) * 1989-12-22 1999-12-27 サントリー株式会社 ベンズオキサジノン誘導体及びそれを有効成分として含有する除草剤
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
CA2713182C (en) 2008-02-20 2016-09-13 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
EP2344495B1 (en) 2008-10-07 2014-12-31 Actelion Pharmaceuticals Ltd. Tricyclic oxazolidinone antibiotic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (pt) * 1962-11-23
US3715353A (en) * 1970-10-12 1973-02-06 Squibb & Sons Inc (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds
CH624395A5 (pt) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2912445A1 (de) * 1979-03-29 1980-10-09 Thiemann Chem Pharm Fab 2-methylen-2,3-dihydro-3-oxo-4h-1,4- benzothiazin-1,1-dioxid-verbindungen, ihre herstellung und verwendung
JPS5651465A (en) * 1979-10-02 1981-05-09 Yoshitomi Pharmaceut Ind Ltd Benzothiazine derivative
JPS5721377A (en) * 1980-07-11 1982-02-04 Shionogi & Co Ltd 3-substituted-1,2-benzisoxazole derivative
JPH08221377A (ja) * 1995-02-20 1996-08-30 Hitachi Ltd データ転送再スケジュール制御方法

Also Published As

Publication number Publication date
IT8249313A0 (it) 1982-10-20
PT77532A (en) 1983-11-01
EP0106816A2 (en) 1984-04-25
ES8504158A1 (es) 1985-04-16
IT1212552B (it) 1989-11-30
CA1215366A (en) 1986-12-16
US4535079A (en) 1985-08-13
AU2028283A (en) 1984-05-03
EP0106816A3 (en) 1984-06-20
ES526569A0 (es) 1985-04-16
JPS59108773A (ja) 1984-06-23

Similar Documents

Publication Publication Date Title
HUT39739A (en) Process for production of derivatives of 13,3-milbemycin and medical preparatives containing thereof
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
ZA82158B (en) New furo-(3,4-c)-pyridine derivatives, process of preparation of the same and therapeutical composition containing the same
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
HK49188A (en) Acyl derivatives of 1,4:3,6-dianhydro-hexitoles,method for their preparation and their pharmaceutical use
GB2095668B (en) Acylquinolinone derivatives process for their manufacture pharmaceutical preparations containing them and their use
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
DE3476656D1 (en) Derivatives of beta-amino-gamma-trimethylammonio-butyrate, their production and use
ZA825876B (en) Novel cyclophoshamide derivatives process for their preparation and their use
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
ZA848303B (en) 1,2-dithiolan derivatives,process for their production,pharmaceutical compositions containing them and their use
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3268047D1 (en) Production of 11,11,12,12-tetracyano-9,10-anthraquinodimethane and derivatives thereof
PT77532B (en) Alkanolaminoxy derivatives of 3,3-dihydro-2h-1,4-benzothiazin-3-one their production process and their pharmaceutical use
HUT37414A (en) Process for production of derivatives of diamine and medical preparatives consisting of such substances
MY8600467A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, process for their production and pharmaceutical compositions comprising them
PH16128A (en) Benzodiazepine derivatives,their pharmaceutical composition and method of use
ZA837286B (en) 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
GB2129427B (en) 15-cycloaliphatic derivatives of 13,14-didehydrocarboprostacyclins and process for their preparation
IL86719A0 (en) Acyl derivatives,their manufacture and pharmaceutical compositions containing them
DE3267376D1 (en) Quinidines, process for their preparation and their pharmaceutical application
GB2108502B (en) N-substituted ergoline- and 9,10-didehydro-ergoline-8-carboxamide- and 8-aminomethyl-derivatives, their production and their pharmaceutical composition
KE3796A (en) Acyl derivatives of 1,4:3,6-dianhydrohexites,processes for their preparation and their use as drugs
GB2156342B (en) 13,14,19,20-tetradehydro derivatives of carboprostacyclins and process for their preparation